{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:37:43Z","timestamp":1793770663834,"version":"4.6.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20328"],"award-info":[{"award-number":["U22A20328"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["W2412035"],"award-info":[{"award-number":["W2412035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22074043"],"award-info":[{"award-number":["22074043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-66976-2","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T06:36:28Z","timestamp":1765866988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Polypeptide sono-adjuvant for ultrasound-activatable regulation of innate immunity and cancer vaccination therapy"],"prefix":"10.1038","volume":"17","author":[{"given":"Fangmin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2673-4618","authenticated-orcid":false,"given":"Yi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0912-8372","authenticated-orcid":false,"given":"Zhixiong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3096-4981","authenticated-orcid":false,"given":"Xiaolong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4391-2507","authenticated-orcid":false,"given":"Zhiai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3398-0880","authenticated-orcid":false,"given":"Haijun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"66976_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41577-024-01091-9","volume":"25","author":"F Baharom","year":"2025","unstructured":"Baharom, F., Hermans, D., Delamarre, L. & Seder, R. A. Vax-Innate: improving therapeutic cancer vaccines by modulating T cells and the tumour microenvironment. Nat. Rev. Immunol. 25, 195\u2013211 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"66976_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nri1396","volume":"4","author":"RJ Ulevitch","year":"2004","unstructured":"Ulevitch, R. J. Therapeutics targeting the innate immune system. Nat. Rev. Immunol. 4, 512\u2013520 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"66976_CR3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.scib.2023.03.041","volume":"68","author":"F Chen","year":"2023","unstructured":"Chen, F. & Yu, H. The advancement of metalloadjuvant for cancer immunotherapy. Sci. Bull. (Beijing) 68, 756\u2013758 (2023).","journal-title":"Sci. Bull. (Beijing)"},{"key":"66976_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni.3123","volume":"16","author":"A Iwasaki","year":"2015","unstructured":"Iwasaki, A. & Medzhitov, R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 16, 343\u2013353 (2015).","journal-title":"Nat. Immunol."},{"key":"66976_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","volume":"574","author":"O Demaria","year":"2019","unstructured":"Demaria, O. et al. Harnessing innate immunity in cancer therapy. Nature 574, 45\u201356 (2019).","journal-title":"Nature"},{"key":"66976_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120709","volume":"270","author":"F Chen","year":"2021","unstructured":"Chen, F. et al. Nanobiomaterial-based vaccination immunotherapy of cancer. Biomaterials 270, 120709 (2021).","journal-title":"Biomaterials"},{"key":"66976_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.immuni.2024.03.007","volume":"57","author":"T Pradeu","year":"2024","unstructured":"Pradeu, T., Thomma, B., Girardin, S. E. & Lemaitre, B. The conceptual foundations of innate immunity: taking stock 30 years later. Immunity 57, 613\u2013631 (2024).","journal-title":"Immunity"},{"key":"66976_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","volume":"57","author":"T Kawai","year":"2024","unstructured":"Kawai, T., Ikegawa, M., Ori, D. & Akira, S. Decoding Toll-like receptors: recent insights and perspectives in innate immunity. Immunity 57, 649\u2013673 (2024).","journal-title":"Immunity"},{"key":"66976_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","volume":"8","author":"T Zhao","year":"2023","unstructured":"Zhao, T. et al. Vaccine adjuvants: mechanisms and platforms. Signal Transduct. Target Ther. 8, 283 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"66976_CR10","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.7150\/thno.84443","volume":"13","author":"T Su","year":"2023","unstructured":"Su, T. et al. Lymph node-targeting adjuvant\/neoantigen-codelivering vaccines for combination glioblastoma radioimmunotherapy. Theranostics 13, 4304\u20134315 (2023).","journal-title":"Theranostics"},{"key":"66976_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jconrel.2022.09.015","volume":"351","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Lymph node-targeting nanovaccines for cancer immunotherapy. J. Control Release 351, 102\u2013122 (2022).","journal-title":"J. Control Release"},{"key":"66976_CR12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.tcb.2022.11.001","volume":"33","author":"C Chen","year":"2023","unstructured":"Chen, C. & Xu, P. Cellular functions of cGAS-STING signaling. Trends Cell Biol. 33, 630\u2013648 (2023).","journal-title":"Trends Cell Biol."},{"key":"66976_CR13","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni.3558","volume":"17","author":"Q Chen","year":"2016","unstructured":"Chen, Q., Sun, L. & Chen, Z. J. Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing. Nat. Immunol. 17, 1142\u20131149 (2016).","journal-title":"Nat. Immunol."},{"key":"66976_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-024-01765-9","volume":"9","author":"A Hu","year":"2024","unstructured":"Hu, A. et al. Harnessing innate immune pathways for therapeutic advancement in cancer. Signal Transduct. Target Ther. 9, 68 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"66976_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba6098","volume":"369","author":"BS Pan","year":"2020","unstructured":"Pan, B. S. et al. An orally available non-nucleotide STING agonist with antitumor activity. Science 369, eaba6098 (2020).","journal-title":"Science"},{"key":"66976_CR16","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1126\/science.abb4255","volume":"369","author":"EN Chin","year":"2020","unstructured":"Chin, E. N. et al. Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic. Science 369, 993\u2013999 (2020).","journal-title":"Science"},{"key":"66976_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202307272","volume":"62","author":"J Yu","year":"2023","unstructured":"Yu, J. et al. Polymeric STING pro-agonists for tumor-specific sonodynamic immunotherapy. Angew. Chem. Int Ed. Engl. 62, e202307272 (2023).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"66976_CR18","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nnano.2017.52","volume":"12","author":"M Luo","year":"2017","unstructured":"Luo, M. et al. A STING-activating nanovaccine for cancer immunotherapy. Nat. Nanotechnol. 12, 648\u2013654 (2017).","journal-title":"Nat. Nanotechnol."},{"key":"66976_CR19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41551-024-01194-7","volume":"8","author":"D Lee","year":"2024","unstructured":"Lee, D. et al. Synthetic cationic helical polypeptides for the stimulation of antitumour innate immune pathways in antigen-presenting cells. Nat. Biomed. Eng. 8, 593\u2013610 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"66976_CR20","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1021\/acs.nanolett.0c01140","volume":"20","author":"L Zhou","year":"2020","unstructured":"Zhou, L. et al. Engineering polymeric prodrug nanoplatform for vaccination immunotherapy of cancer. Nano Lett. 20, 4393\u20134402 (2020).","journal-title":"Nano Lett."},{"key":"66976_CR21","doi-asserted-by":"publisher","first-page":"10823","DOI":"10.1021\/ja412314j","volume":"136","author":"KA Ryu","year":"2014","unstructured":"Ryu, K. A., Stutts, L., Tom, J. K., Mancini, R. J. & Esser-Kahn, A. P. Stimulation of innate immune cells by light-activated TLR7\/8 agonists. J. Am. Chem. Soc. 136, 10823\u201310825 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"66976_CR22","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.1039\/D3SC01896B","volume":"14","author":"C Ding","year":"2023","unstructured":"Ding, C. et al. Photochemically controlled activation of STING by CAIX-targeting photocaged agonists to suppress tumor cell growth. Chem. Sci. 14, 5956\u20135964 (2023).","journal-title":"Chem. Sci."},{"key":"66976_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41164-2","volume":"14","author":"Y Dou","year":"2023","unstructured":"Dou, Y. et al. Optogenetic engineering of STING signaling allows remote immunomodulation to enhance cancer immunotherapy. Nat. Commun. 14, 5461 (2023).","journal-title":"Nat. Commun."},{"key":"66976_CR24","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41551-021-00779-w","volume":"5","author":"Y Wu","year":"2021","unstructured":"Wu, Y. et al. Control of the activity of CAR-T cells within tumours via focused ultrasound. Nat. Biomed. Eng. 5, 1336\u20131347 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"66976_CR25","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.1021\/acsbiomaterials.0c01162","volume":"6","author":"MM Binkley","year":"2020","unstructured":"Binkley, M. M., Cui, M., Berezin, M. Y. & Meacham, J. M. Antibody conjugate assembly on ultrasound-confined microcarrier particles. ACS Biomater. Sci. Eng. 6, 6108\u20136116 (2020).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"66976_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202211130","volume":"35","author":"S Liang","year":"2023","unstructured":"Liang, S. et al. Harnessing nanomaterials for cancer sonodynamic immunotherapy. Adv. Mater. 35, e2211130 (2023).","journal-title":"Adv. Mater."},{"key":"66976_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41551-022-00978-z","volume":"7","author":"C Xu","year":"2023","unstructured":"Xu, C. et al. Nanoparticles with ultrasound-induced afterglow luminescence for tumour-specific theranostics. Nat. Biomed. Eng. 7, 298\u2013312 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"66976_CR28","first-page":"2303899","volume":"33","author":"M Zhou","year":"2023","unstructured":"Zhou, M. et al. Vitamin B2-based ferroptosis promoter for sono-enhanced nanocatalytic therapy of triple-negative. Breast Cancer 33, 2303899 (2023).","journal-title":"Breast Cancer"},{"key":"66976_CR29","first-page":"2100386","volume":"31","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. Endogenous stimuli-activatable. Nanomed. Immune Theranostics Cancer 31, 2100386 (2021).","journal-title":"Nanomed. Immune Theranostics Cancer"},{"key":"66976_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23482-5","volume":"12","author":"H Atcha","year":"2021","unstructured":"Atcha, H. et al. Mechanically activated ion channel Piezo1 modulates macrophage polarization and stiffness sensing. Nat. Commun. 12, 3256 (2021).","journal-title":"Nat. Commun."},{"key":"66976_CR31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41586-019-1499-2","volume":"573","author":"YC Lin","year":"2019","unstructured":"Lin, Y. C. et al. Force-induced conformational changes in PIEZO1. Nature 573, 230\u2013234 (2019).","journal-title":"Nature"},{"key":"66976_CR32","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/s41565-024-01758-3","volume":"19","author":"M Tan","year":"2024","unstructured":"Tan, M. et al. Metal-ion-chelating phenylalanine nanostructures reverse immune dysfunction and sensitize breast tumour to immune checkpoint blockade. Nat. Nanotechnol. 19, 1903\u20131913 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"66976_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature11588","volume":"492","author":"GS Lee","year":"2012","unstructured":"Lee, G. S. et al. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 492, 123\u2013127 (2012).","journal-title":"Nature"},{"key":"66976_CR34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139333","volume":"131","author":"M Hu","year":"2021","unstructured":"Hu, M. et al. ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS\/STING activation. J. Clin. Invest 131, e139333 (2021).","journal-title":"J. Clin. Invest"},{"key":"66976_CR35","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41590-020-0699-0","volume":"21","author":"M Jia","year":"2020","unstructured":"Jia, M. et al. Redox homeostasis maintained by GPX4 facilitates STING activation. Nat. Immunol. 21, 727\u2013735 (2020).","journal-title":"Nat. Immunol."},{"key":"66976_CR36","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/nbt.3371","volume":"33","author":"GM Lynn","year":"2015","unstructured":"Lynn, G. M. et al. In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity. Nat. Biotechnol. 33, 1201\u20131210 (2015).","journal-title":"Nat. Biotechnol."},{"key":"66976_CR37","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nbt.3398","volume":"33","author":"EL Dane","year":"2015","unstructured":"Dane, E. L. & Irvine, D. J. Big thinking for adjuvants. Nat. Biotechnol. 33, 1146\u20131148 (2015).","journal-title":"Nat. Biotechnol."},{"key":"66976_CR38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.addr.2019.09.005","volume":"151-152","author":"X Ke","year":"2019","unstructured":"Ke, X. et al. Physical and chemical profiles of nanoparticles for lymphatic targeting. Adv. Drug Deliv. Rev. 151-152, 72\u201393 (2019).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"66976_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113914","volume":"179","author":"Y Ding","year":"2021","unstructured":"Ding, Y., Li, Z., Jaklenec, A. & Hu, Q. Vaccine delivery systems toward lymph nodes. Adv. Drug Deliv. Rev. 179, 113914 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"66976_CR40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2121098119","volume":"119","author":"A Singh","year":"2022","unstructured":"Singh, A. et al. Nanoparticle targeting of de novo profibrotic macrophages mitigates lung fibrosis. Proc. Natl. Acad. Sci. USA 119, e2121098119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66976_CR41","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1016\/j.apsb.2024.06.003","volume":"14","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. In situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases. Acta Pharm. Sin. B 14, 4102\u20134117 (2024).","journal-title":"Acta Pharm. Sin. B"},{"key":"66976_CR42","doi-asserted-by":"publisher","first-page":"15557","DOI":"10.1021\/acsnano.4c00392","volume":"18","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. Dual-targeted self-adjuvant heterocyclic lipidoid@polyester hybrid nanovaccines for boosting cancer immunotherapy. ACS Nano 18, 15557\u201315575 (2024).","journal-title":"ACS Nano"},{"key":"66976_CR43","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1158\/0008-5472.CAN-12-3788","volume":"73","author":"N Bacher","year":"2013","unstructured":"Bacher, N. et al. Interferon-alpha suppresses cAMP to disarm human regulatory T cells. Cancer Res. 73, 5647\u20135656 (2013).","journal-title":"Cancer Res."},{"key":"66976_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00018-022-04219-z","volume":"79","author":"R Yu","year":"2022","unstructured":"Yu, R., Zhu, B. & Chen, D. Type I interferon-mediated tumor immunity and its role in immunotherapy. Cell Mol. Life Sci. 79, 191 (2022).","journal-title":"Cell Mol. Life Sci."},{"key":"66976_CR45","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.it.2017.05.005","volume":"38","author":"LM Snell","year":"2017","unstructured":"Snell, L. M., McGaha, T. L. & Brooks, D. G. Type I interferon in chronic virus infection and cancer. Trends Immunol. 38, 542\u2013557 (2017).","journal-title":"Trends Immunol."},{"key":"66976_CR46","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41565-024-01615-3","volume":"19","author":"YC Zeng","year":"2024","unstructured":"Zeng, Y. C. et al. Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination. Nat. Nanotechnol. 19, 1055\u20131065 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"66976_CR47","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1021\/accountsmr.2c00042","volume":"3","author":"J Ye","year":"2022","unstructured":"Ye, J., Hou, B., Saeed, M., Xu, Z. & Yu, H. Engineering bioinspired nanomedicines to mitigate the resistance to cancer immunotherapy. Acc. Mater. Res. 3, 697\u2013708 (2022).","journal-title":"Acc. Mater. Res."},{"key":"66976_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2024.102273","volume":"56","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. In-situ vaccination immunotherapy of colorectal cancer with STING agonist-integrated supramolecular nanovectors. Nano Today 56, 102273 (2024).","journal-title":"Nano Today"},{"key":"66976_CR49","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41565-020-00782-3","volume":"15","author":"N Gong","year":"2020","unstructured":"Gong, N. et al. Proton-driven transformable nanovaccine for cancer immunotherapy. Nat. Nanotechnol. 15, 1053\u20131064 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"66976_CR50","doi-asserted-by":"publisher","first-page":"27336","DOI":"10.1021\/jacs.3c07491","volume":"145","author":"L Yu","year":"2023","unstructured":"Yu, L. et al. CytoDirect: a nucleic acid nanodevice for specific and efficient delivery of functional payloads to the cytoplasm. J. Am. Chem. Soc. 145, 27336\u201327347 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"66976_CR51","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1124\/mol.113.089821","volume":"85","author":"M Lamphier","year":"2014","unstructured":"Lamphier, M. et al. Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo. Mol. Pharm. 85, 429\u2013440 (2014).","journal-title":"Mol. Pharm."},{"key":"66976_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05815-y","volume":"14","author":"J Lu","year":"2023","unstructured":"Lu, J. et al. TLR7-MyD88-DC-CXCL16 axis results neutrophil activation to elicit inflammatory response in pustular psoriasis. Cell Death Dis. 14, 315 (2023).","journal-title":"Cell Death Dis."},{"key":"66976_CR53","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nri3845","volume":"15","author":"L Zitvogel","year":"2015","unstructured":"Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M. J. & Kroemer, G. Type I interferons in anticancer immunity. Nat. Rev. Immunol. 15, 405\u2013414 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"66976_CR54","doi-asserted-by":"publisher","first-page":"e2209910","DOI":"10.1002\/adma.202209910","volume":"35","author":"F Chen","year":"2022","unstructured":"Chen, F. et al. Acid-Ionizable iron nanoadjuvant augments STING activation for personalized vaccination immunotherapy of cancer. Adv. Mater. 35, e2209910 (2022).","journal-title":"Adv. Mater."},{"key":"66976_CR55","doi-asserted-by":"crossref","unstructured":"Saeed, M. et al. From design to clinic: engineered nanobiomaterials for immune normalization therapy of cancer. Adv. Mater. 33, 2008094 (2021).","DOI":"10.1002\/adma.202008094"},{"key":"66976_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01467-8","volume":"20","author":"Z Cai","year":"2021","unstructured":"Cai, Z. et al. Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion. Mol. Cancer 20, 164 (2021).","journal-title":"Mol. Cancer"},{"key":"66976_CR57","doi-asserted-by":"publisher","first-page":"e004389","DOI":"10.1136\/jitc-2021-004389","volume":"10","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. Personalized neoantigen vaccine combined with PD-1 blockade increases CD8(+) tissue-resident memory T-cell infiltration in preclinical hepatocellular carcinoma models. J. Immunother. Cancer 10, e004389 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"66976_CR58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","volume":"8","author":"N Xie","year":"2023","unstructured":"Xie, N. et al. Neoantigens: promising targets for cancer therapy. Signal Transduct. Target Ther. 8, 9 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"66976_CR59","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.32740","volume":"77","author":"R Donne","year":"2023","unstructured":"Donne, R. & Lujambio, A. The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma. Hepatology 77, 1773\u20131796 (2023).","journal-title":"Hepatology"},{"key":"66976_CR60","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","volume":"18","author":"B Sangro","year":"2021","unstructured":"Sangro, B., Sarobe, P., Hervas-Stubbs, S. & Melero, I. Advances in immunotherapy for hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 18, 525\u2013543 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"66976_CR61","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","volume":"19","author":"JM Llovet","year":"2022","unstructured":"Llovet, J. M. et al. Immunotherapies for hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 19, 151\u2013172 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"66976_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202300854","volume":"35","author":"J Jiang","year":"2023","unstructured":"Jiang, J. et al. Sono-driven STING activation using semiconducting polymeric nanoagonists for precision sono-immunotherapy of head and neck squamous cell carcinoma. Adv. Mater. 35, e2300854 (2023).","journal-title":"Adv. Mater."},{"key":"66976_CR63","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.it.2007.03.008","volume":"28","author":"A Macagno","year":"2007","unstructured":"Macagno, A., Napolitani, G., Lanzavecchia, A. & Sallusto, F. Duration, combination and timing: the signal integration model of dendritic cell activation. Trends Immunol. 28, 227\u2013233 (2007).","journal-title":"Trends Immunol."},{"key":"66976_CR64","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature09737","volume":"470","author":"SP Kasturi","year":"2011","unstructured":"Kasturi, S. P. et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470, 543\u2013547 (2011).","journal-title":"Nature"},{"key":"66976_CR65","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41565-022-01296-w","volume":"18","author":"SM Jin","year":"2023","unstructured":"Jin, S. M. et al. A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion. Nat. Nanotechnol. 18, 390\u2013402 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"66976_CR66","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/s41551-024-01209-3","volume":"8","author":"AJ Najibi","year":"2024","unstructured":"Najibi, A. J. et al. Durable lymph-node expansion is associated with the efficacy of therapeutic vaccination. Nat. Biomed. Eng. 8, 1226\u20131242 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"66976_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202414555","volume":"37","author":"Z Han","year":"2025","unstructured":"Han, Z. et al. Precise cell type electrical stimulation therapy via force-electric hydrogel microspheres for cartilage healing. Adv. Mater. 37, e2414555 (2025).","journal-title":"Adv. Mater."},{"key":"66976_CR68","doi-asserted-by":"crossref","unstructured":"Zhu, K. et al. Ultrasound-activated theranostic materials and their bioapplications. Angew. Chem. Int. Ed. 64, e202422278 (2025).","DOI":"10.1002\/anie.202422278"},{"key":"66976_CR69","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jconrel.2023.02.009","volume":"355","author":"F Moradi Kashkooli","year":"2023","unstructured":"Moradi Kashkooli, F., Jakhmola, A., Hornsby, T. K., Tavakkoli, J. J. & Kolios, M. C. Ultrasound-mediated nano drug delivery for treating cancer: fundamental physics to future directions. J. Control Release 355, 552\u2013578 (2023).","journal-title":"J. Control Release"},{"key":"66976_CR70","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1517\/17425247.3.6.713","volume":"3","author":"S Paliwal","year":"2006","unstructured":"Paliwal, S. & Mitragotri, S. Ultrasound-induced cavitation: applications in drug and gene delivery. Expert Opin. Drug Deliv. 3, 713\u2013726 (2006).","journal-title":"Expert Opin. Drug Deliv."},{"key":"66976_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202300066","volume":"35","author":"CC Yu","year":"2023","unstructured":"Yu, C. C. et al. A conformable ultrasound patch for cavitation-enhanced transdermal cosmeceutical delivery. Adv. Mater. 35, e2300066 (2023).","journal-title":"Adv. Mater."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66976-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66976-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66976-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T15:04:23Z","timestamp":1767884663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66976-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["66976"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66976-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"1 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}